InsiderTrades

Form 4 for NEO NEOGENOMICS INC

Accepted 2025-05-13 00:00:00 ET · period of report 2025-05-11 · accession 0001077183-25-000104 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-05-13 2025-05-11 NEO Stone Warren Pres, COO M - OptEx $0.00 +9,613 104.9K +10% $0
D 2025-05-13 2025-05-11 NEO Stone Warren Pres, COO F - Tax $0.00 -2,341 102.6K -2% $0
D 2025-05-13 2025-05-12 NEO Stone Warren Pres, COO P - Purchase $8.58 +5,700 108.3K +6% +$48.9K
D 2025-05-13 2025-05-11 NEO Stone Warren Pres, COO M - OptEx $0.00 -9,613 9,613 -50% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-05-11 M A 9,613 $0.00 104,921 D — — (F1) Each restricted stock unit is the economic equivalent of one share of NeoGenomics common stock and is converted into common stock upon vesting.
2 Common Common Stock 2025-05-11 F D 2,341 $0.00 102,580 D — — (F2) Disposition of shares was in connection with the Issuer's withholding of common stock to satisfy tax withholding obligations related to the issuance of common stock upon release of restricted stock units.
3 Common Common Stock 2025-05-12 P A 5,700 $8.58 108,280 D — —
4 Derivative Restricted Stock Unit 2025-05-11 M D 9,613 $0.00 9,613 D $0.00 · — to — 9,613 Common Stock (F3) On May 11, 2023, Mr. Stone was granted 28,838 restricted stock units. The restricted stock units vest ratably over the first three anniversary dates of the grant date. (F4) Once vested, the shares of common stock are not subject to expiration.